Metacrine Correlations

MTCRDelisted Stock  USD 0.49  0.00  0.00%   
The current 90-days correlation between Metacrine and Magenta Therapeutics is 0.12 (i.e., Average diversification). The correlation of Metacrine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Metacrine Correlation With Market

Very good diversification

The correlation between Metacrine and DJI is -0.3 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Moving together with Metacrine Stock

  0.68ZM Zoom Video Communications Earnings Call This WeekPairCorr
  0.75GM General Motors Aggressive PushPairCorr
  0.64MRVL Marvell Technology Earnings Call This WeekPairCorr

Moving against Metacrine Stock

  0.56CSLLY CSLPairCorr
  0.53CMXHF CSL LimitedPairCorr
  0.53REGN Regeneron PharmaceuticalsPairCorr
  0.4NVO Novo Nordisk ASPairCorr
  0.4NONOF Novo Nordisk ASPairCorr
  0.34QSAM Qsam BiosciencesPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VCNXNUVB
TARAMGTA
CTMXNLTX
VCNXTCON
VCNXNLTX
STSATARA
  
High negative correlations   
CTMXTARA
TILMGTA
CTMXSTSA
NLTXSTSA
TILSTSA
VCNXSTSA

Risk-Adjusted Indicators

There is a big difference between Metacrine Stock performing well and Metacrine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Metacrine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MGTA  2.62  0.19  0.00 (0.19) 3.40 
 5.88 
 16.99 
TARA  3.03  0.23  0.04  7.52  2.96 
 7.26 
 19.48 
TCON  6.84 (1.89) 0.00 (4.58) 0.00 
 19.59 
 52.05 
STSA  3.39  0.58  0.09 (0.79) 3.54 
 5.71 
 70.12 
NLTX  2.25 (0.22) 0.00 (0.55) 0.00 
 4.05 
 27.84 
CTMX  2.58 (0.53) 0.00 (0.35) 0.00 
 5.00 
 20.61 
ASMB  2.91  0.09  0.00  0.31  4.46 
 8.49 
 24.80 
TIL  9.42  1.47  0.25  0.40  6.84 
 20.63 
 105.83 
NUVB  3.76 (0.36) 0.00  0.03  4.59 
 9.48 
 21.30 
VCNX  6.00 (0.21) 0.00 (0.22) 0.00 
 11.11 
 54.95 

View Metacrine Related Equities

 Risk & Return  Correlation

Metacrine Corporate Management

Still Interested in Metacrine?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.